Basic info
Industry
biotechnology research
Sectors
Biotechnology
cancer
Biopharma
clinical trials
Health Care
biomarker discovery
Therapeutics
Drug discovery and development
Genetics
Medical
neurodegeneration
epigenetics
Date founded
2000
Funding rounds raised
Total raised
$21M
from 4 investors over 4 rounds
O
Oryzon Genomics SA raised $425K on December 16, 2022
Investors: European Union
O
Oryzon Genomics SA raised $21M on July 5, 2022
Investors: Nice & Green SA, Proprietary Equity Investment & Alternative Financing
O
Oryzon Genomics SA raised $2M on June 7, 2022
Investors: European Commission
O
Oryzon Genomics SA raised $1M on September 21, 2021
Investors: Kabuki Syndrome Foundation